Organization
University of Utah
116 clinical trials
46 abstracts
9 posters
Abstract
INDIGO: A global, randomized, double-blinded, phase 3 study of vorasidenib versus placebo in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.Org: Memorial Sloan Kettering Cancer Center, Erasmus MC Cancer Institute, Tel-Aviv Sourasky Medical Center/Tel-Aviv University, Pitié Salpêtrière Hospital, Duke University Medical Center,
Abstract
Belzutifan treatment for von Hippel-Lindau (VHL) disease–associated central nervous system (CNS) hemangioblastomas (HBs) in the phase 2 LITESPARK-004 study.Org: Massachusetts General Hospital Cancer Center and Harvard Medical School, Vanderbilt University Medical Center, University of Utah, Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Merck & Co., Inc.,
Abstract
TALAPRO-2: Phase 3 study of talazoparib (TALA) + enzalutamide (ENZA) versus placebo (PBO) + ENZA as first-line (1L) treatment for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) harboring homologous recombination repair (HRR) gene alterations.Org: University of Paris-Saclay, Peter MacCallum Cancer Centre, Melbourne, Australia, National Cancer Center Hospital East, Kashiwa, Japan, Vall d’Hebron University Hospital/VHIO, Barcelona, Spain,
Abstract
Differential burnout by race, sex, and sexual orientation in academic oncology.Org: University of Utah, Memorial Sloan Kettering Cancer Center, University of California San Francisco, Association of American Medical Colleges,
Abstract
Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022.Org: Duke Cancer Institute, University of California, San Francisco, University of Utah, University of California, Davis Comprehensive Cancer Center, University of Chicago Medicine,
Abstract
I-SPY2 Endocrine Optimization Pilot (EOP): Neoadjuvant amcenestrant +/- abemaciclib +/- letrozole in molecularly selected patients (pts) with HR+ HER2- stage 2/3 breast cancer (BC).Org: University of California, San Francisco, Mayo Clinic, University of Chicago Medical Center, Chicago, IL, Winship Cancer Institute of Emory University, Hunstman Cancer Institute at the University of Utah,
Abstract
Disparities in frontline treatment and overall survival in the era of targeted tyrosine kinase inhibitor therapy for chronic myeloid leukemia: 2004-2021.Org: University of Utah, Huntsman Cancer Institute,
Clinical trial
APK Mutant: A Single Arm Phase II Study of Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal CancerStatus: Terminated, Estimated PCD: 2024-02-20
Clinical trial
A Proof-of-Concept Multicenter Trial Evaluating Response Adapted Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin LymphomaStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR)Status: Terminated, Estimated PCD: 2023-01-12
Clinical trial
A Pilot Study of Atorvastatin as a Potential Adjunct to Misoprostol for Termination of PregnancyStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Clinical trial
A Phase I/II Randomized Double-blinded Placebo-controlled Clinical Trial to Determine Safety and Feasibility of Using an Acellular Sterile Filtered Amniotic Fluid as a Treatment for COVID-19 PatientsStatus: Completed, Estimated PCD: 2022-08-02
Clinical trial
A Phase II Study to Evaluate the Efficacy and Safety of Selinexor in Patients With Myelofibrosis Refractory or Intolerant to JAK1/2 InhibitorsStatus: Active (not recruiting), Estimated PCD: 2023-08-16
Clinical trial
A Phase 1b Trial of a Combination of mFOLFIRI With MEK162 in Patients With Advanced RAS (HRAS, NRAS, or KRAS) Positive Metastatic Colorectal CancersStatus: Completed, Estimated PCD: 2022-12-21
Clinical trial
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)Status: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized TrialStatus: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
Metformin as a Novel, Mechanistic Treatment of Fibromyalgia; a Proof of Concept RCTStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Assessing the Value of 18F-Fluciclovine PET/CT in the Assessment of Pancreatic TransplantsStatus: Completed, Estimated PCD: 2022-10-06
Clinical trial
ASsessment Of RiLuzole To Reduce Paroxysmal Episodes of Atrial FIbrillatiON (The SOLUTION Study)Status: Recruiting, Estimated PCD: 2024-10-30
Clinical trial
RESILIENCE: Effect of Comprehensive Celecoxib Through Treatment for Advanced-Stage Head and Neck Cancer: A Randomized, Double-Blinded, Placebo-Controlled TrialStatus: , Estimated PCD: 2024-10-12
Abstract
H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive (ER+), HER2 negative (–) breast cancer (BC).Org: Sarah Cannon Research Institute/Tennessee Oncology, Saint Luke's Cancer Institute, Florida Cancer Specialists/Sarah Cannon Research Institute, Royal Marsden NHS Foundation Trust, Lineberger Comprehensive Cancer Center,
Abstract
A phase 1 trial evaluating the safety, tolerability, PK, and preliminary efficacy of QTX3034, an oral G12D-preferring multi-KRAS inhibitor, in patients with solid tumors with KRASG12D mutation.Org: Sarah Cannon Research Institute/Tennessee Oncology, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Duke University Medical Center, Huntsman Cancer Institute, University of Utah,
Abstract
Biological subgroups in melanoma: A correlation of tumor genomic and transcriptomic analysis with spatial immunophenotyping.Org: School of Medicine, Zhejiang University, Hangzhou, China, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, Huntsman Cancer Institute at the University of Utah,
Abstract
Evaluating the impact of depression on self-reported quality of life measurements for patients with a history of cancer: A 2022 behavioral risk factor surveillance system questionnaire study.Org: University of Utah, Oregon Health & Science University,
Abstract
Implementing a natural language processing pipeline to expedite clinical chart review to assess germline genetic testing in veterans with breast cancer.Org: VA Salt Lake City Health Care, University of Utah, Durham VA Medical Center, Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, VHA National Oncology Program Office,
Clinical trial
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain TumorsStatus: Terminated, Estimated PCD: 2022-08-20
Abstract
Real world outcomes in patients with follicular lymphoma treated with RCHOP vs BR.Org: Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, Huntsman Cancer Institute/University of Utah, Hunstman Cancer Institute at the University of Utah,
Abstract
Comparative effectiveness of first-line (1L) ipilimumab plus nivolumab (Ipi + Nivo) versus immune checkpoint inhibitors + tyrosine kinase inhibitors (ICI + TKI) in patients (pts) with intermediate or poor (I/P) risk metastatic clear cell renal cell carcinoma (mccRCC).Org: Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, Huntsman Cancer Institute at the University of Utah, University of Utah/Huntsman Cancer Institute,
Clinical trial
Pilot Study of Memantine for Enhanced Stroke RecoveryStatus: Active (not recruiting), Estimated PCD: 2025-05-01
Clinical trial
A Phase II Open Label Single Arm Study of Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer (NEXT)Status: Active (not recruiting), Estimated PCD: 2024-10-31
Clinical trial
Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC): Effectiveness, Side Effects and Neurobiological ChangesStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
A Phase I/II Randomized, Double-Masked Placebo-Controlled Study For Determining The Safety Of Processed Amniotic Fluid (PAF) Drops After Photorefractive KeratectomyStatus: Completed, Estimated PCD: 2023-01-16
Clinical trial
A Phase II Study of Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic Graft Versus Host Disease (GVHD)Status: Terminated, Estimated PCD: 2022-03-29
Clinical trial
TREK: Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI CancersStatus: Recruiting, Estimated PCD: 2024-11-15
Clinical trial
Single-Dose Pharmacokinetics of Atropine Oral Gel in Healthy AdultsStatus: Active (not recruiting), Estimated PCD: 2023-06-30
Clinical trial
Creatine for Treatment of Depression Associated With Type 2 DiabetesStatus: Withdrawn, Estimated PCD: 2024-06-10
Clinical trial
Remimazolam Safety and Efficacy for Nerve BlocksStatus: Completed, Estimated PCD: 2022-08-01
Clinical trial
Novel Imaging Markers of Innate Immune Activation in Secondary Progressive Multiple SclerosisStatus: Completed, Estimated PCD: 2023-09-01
Clinical trial
Pharmacokinetics of L-citrulline in Infants at High Risk of Developing Pulmonary Hypertension Associated With Bronchopulmonary DysplasiaStatus: Terminated, Estimated PCD: 2022-08-31
Clinical trial
A Phase Ib/II Trial of Combination RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic LeukemiaStatus: Recruiting, Estimated PCD: 2025-08-15
Clinical trial
A Pilot Prospective, Randomized Pharmacodynamic Study With Assessment of Ulipristal Acetate on Ovarian Activity Following Quickstart of the Etonogestrel Contraceptive ImplantStatus: Active (not recruiting), Estimated PCD: 2022-10-10
Clinical trial
Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma (PemCab)Status: Active (not recruiting), Estimated PCD: 2023-08-02
Clinical trial
Assessment of Primary and Metastatic Brain Tumor Hypoxia With 18F-Fluoromisonidazole, [18F]Fluoro-2-deoxy-D-glucose (FDG) and [15O]Water (H215O)Status: Terminated, Estimated PCD: 2014-05-03
Clinical trial
A Phase Ib Study to Evaluate the Safety and Efficacy of Osimertinib in Combination With Ipilimumab in Patients With EGFR Mutated Non-Small-Cell Lung Cancer TumorsStatus: Active (not recruiting), Estimated PCD: 2025-04-30
Clinical trial
A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients: the BOOST StudyStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Clinical trial
Evaluating the Effectiveness of Local Multimodal Injection in Controlling Pain, Limiting Complications, and Reducing Cost as Compared to Regional Anesthesia for Treating Rotational Ankle Fractures.Status: , Estimated PCD: 2026-05-01
Clinical trial
Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis (ATIOM)Status: Recruiting, Estimated PCD: 2024-10-30
Clinical trial
Pilot for Vancomycin and Tobramycin Powder Use in Acute Open Fractures in the Emergency DepartmentStatus: , Estimated PCD: 2028-03-01
Clinical trial
Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part IIStatus: Active (not recruiting), Estimated PCD: 2022-06-01
Clinical trial
Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation TherapyStatus: Recruiting, Estimated PCD: 2025-04-30
Clinical trial
Intradiscal Platelet-Rich Plasma Injection for Chronic Discogenic Low Back PainStatus: Terminated, Estimated PCD: 2022-07-29
Clinical trial
Estradiol Supplementation and Rotator Cuff Repair: A Preliminary Randomized TrialStatus: Not yet recruiting, Estimated PCD: 2028-03-01
Clinical trial
Prospective Evaluation Analysis and Kinetics of IV SotalolStatus: Completed, Estimated PCD: 2023-08-30
Clinical trial
RESOLVE : A Phase I Trial of Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in ARID1A Mutated Cancers With Focus on Urothelial CarcinomaStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
Determining the Role of Periarticular Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau FracturesStatus: Active (not recruiting), Estimated PCD: 2026-03-01
Clinical trial
A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With CancerStatus: Completed, Estimated PCD: 2022-06-11
Clinical trial
THREAD: A Phase I Trial of Trametinib and Hydroxychloroquine in Patients With Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2025-01-18
Clinical trial
Use of Metformin to Improve Muscle Regrowth in Older AdultsStatus: Not yet recruiting, Estimated PCD: 2029-07-31
Clinical trial
Beta-Receptor SELECTivity of Carvedilol and Metoprolol Succinnate in Patients With Heart Failure: A Randomized Dose Ranging Trial (SELECT Trial)Status: Completed, Estimated PCD: 2004-12-01
Clinical trial
Exploring the Mechanisms Underlying the Analgesic Properties of Cannabidiol Using Magnetic Resonance SpectroscopyStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive DisorderStatus: Completed, Estimated PCD: 2023-08-02
Clinical trial
Periarticular Infusion With Liposomal Bupivacaine or a Ropivacaine Cocktail Versus Continuous Femoral Nerve Catheters for Multimodal Pain Management Following Primary TKA: A Randomized Controlled TrialStatus: Terminated, Estimated PCD: 2017-04-01
Clinical trial
Phase 2 Trial of Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway MutationsStatus: Recruiting, Estimated PCD: 2025-08-15
Clinical trial
A Prospective Trial to Assess How Glycopyrronium Cloths at the Amputation Site of Limb Amputees Changes the Severity of Hyperhidrosis and the Fit and Function of the Prosthetic Measured by Patient Reported OutcomesStatus: Completed, Estimated PCD: 2023-12-02
Clinical trial
Metformin to Prevent Inactivity-induced Loss of Muscle Health During AgingStatus: Active (not recruiting), Estimated PCD: 2024-04-30
Clinical trial
Randomized Phase 2 Studying the Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia (CLL) With History of Non-melanoma Skin Cancers (NMSC)Status: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Phase I Trial of Ulixertinib (BVD-523) and Hydroxychloroquine in Patients With Advanced MAPK-Mutated Gastrointestinal AdenocarcinomasStatus: Completed, Estimated PCD: 2022-06-10
Clinical trial
A Phase II Randomized Controlled Trial of a Supplement Containing Quercetin, Bromelain, Rye Flower Pollen, and Papain on Reducing the Severity of Radiation-Induced ProstatitisStatus: , Estimated PCD: 2025-06-01
Clinical trial
A Phase 2 Study of Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to BoneStatus: Completed, Estimated PCD: 2022-09-30
Clinical trial
Phase II Study of Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable MelanomaStatus: Not yet recruiting, Estimated PCD: 2026-08-01
Clinical trial
A Phase I/Ib Trial of the CDK4/6 Antagonist Ribociclib And The HDAC Inhibitor Belinostat In Patients With Metastatic Triple Negative Breast Cancer And Recurrent Ovarian Cancer With Response Prediction By Genomics (CHARGE)Status: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Randomized, Efficacy Assessor-Blinded, Study to Assess Preliminary Efficacy and Safety of EDTA Eye Drops v. an Active Comparator in the Suppression of Herpes Simplex Virus Eruptions in Subjects With a History of Herpes LabialisStatus: , Estimated PCD: 2024-08-01
Clinical trial
Impact of T Cells on Age-related Vascular Dysfunction: A Translational ApproachStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
Intravenous Magnesium: Prompt Use for Asthma in Children Treated in the Emergency DepartmentStatus: Completed, Estimated PCD: 2023-05-31
Clinical trial
Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic TraumaStatus: Completed, Estimated PCD: 2019-06-30
Clinical trial
A Phase I/II Double-Blinded Randomized Prospective Study of Sterile Amniotic Fluid Filtrate Epidural Injection for the Treatment of Lumbosacral Radicular Pain Due to Spinal Stenosis: Improving Safety and Outcomes in the Treatment of Pain and Disability Related to Spinal Stenosis.Status: Recruiting, Estimated PCD: 2025-01-20
Clinical trial
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ MalignanciesStatus: Recruiting, Estimated PCD: 2026-01-15
Clinical trial
Phase 1b/2 Trial of Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous MelanomaStatus: Recruiting, Estimated PCD: 2028-01-15
Clinical trial
Effects of St. John's Wort on LevonorgestrelStatus: Completed, Estimated PCD: 2008-05-01
Clinical trial
Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)Status: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
Prospective Randomized Trial Using Medrol Dose Packs for Post-Operative Pain ControlStatus: , Estimated PCD: 2025-01-01
Clinical trial
AtezoCab: A Phase II Study of Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Non-Measurable DiseaseStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Feasibility Study to Evaluate the Addition of Tumor Treating Fields to Treatment of Locally Advanced Stage III NSCLCStatus: Recruiting, Estimated PCD: 2025-11-15
Clinical trial
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Metastatic Colorectal CancerStatus: Not yet recruiting, Estimated PCD: 2027-07-01
Clinical trial
A Pilot Randomized Controlled Trial of Low Molecular Weight Heparin or no Treatment Following Cesarean DeliveryStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)Status: Recruiting, Estimated PCD: 2026-04-30
Clinical trial
A Randomized, Phase II Study of Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed and Carboplatin (PC) for Metastatic Non-Squamous NSCLCStatus: Recruiting, Estimated PCD: 2025-02-15
Clinical trial
The Effectiveness of Cervical Transforaminal Epidural Steroid Injection for the Treatment of Cervical Radicular Pain: A Prospective Cohort Study.Status: Completed, Estimated PCD: 2022-10-31
Clinical trial
Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.Status: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Intra-articular Platelet-Rich Plasma in the Management of Acetabular Labral Tears: a Prospective StudyStatus: Recruiting, Estimated PCD: 2025-01-25
Clinical trial
Hematoma Block vs. Bier Block: Which is More Effective for Closed Fracture Reduction?Status: , Estimated PCD: 2025-07-01
Clinical trial
A Phase Ib Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Status: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Phase II Study of the Efficacy of the Pneumococcal Pneumonia Vaccine Series in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency (PROTECT CLL)Status: Recruiting, Estimated PCD: 2025-01-07
Clinical trial
A Randomized Phase 2 Trial Investigating the Impact of Budesonide Prophylaxis on Incidence of ≥ Grade 2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell TransplantStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
A Phase IB Study of Nivolumab in Combination With Radium-223 in Men With Metastatic Castration Resistant Prostate CancerStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day StartStatus: Recruiting, Estimated PCD: 2027-03-31
Clinical trial
A Phase 2 Umbrella Protocol of Enfortumab Vedotin as Monotherapy and Combined With Other Agents in Patients With Metastatic Castration-Resistant Prostate CancerStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Neural and Antidepressant Effects of PropofolStatus: Active (not recruiting), Estimated PCD: 2022-12-31
Clinical trial
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-Nmda Receptor Encephalitis and Assess Markers of DiseaseStatus: Recruiting, Estimated PCD: 2025-10-31
Clinical trial
A Multimodal Analgesia Protocol Adapted for Ambulatory SurgeryStatus: Completed, Estimated PCD: 2023-01-31
Clinical trial
Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive ImpairmentStatus: Active (not recruiting), Estimated PCD: 2025-01-01
Clinical trial
A Phase I/II Randomized Double-Blinded Standard of Care (Corticosteroid) vs. Sterile Amniotic Fluid for OsteoarthritisStatus: Recruiting, Estimated PCD: 2024-07-30
Clinical trial
A Randomized, Double-Blinded, Placebo-Controlled Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)Status: Completed, Estimated PCD: 2022-12-16
Clinical trial
Pilot Study to Assess Impact of Kuvan® Supplementation as an Adjunct Treatment in Subjects With Dominantly-inherited GTPCH Deficiency on Mood, Behavioral and Motor PhenotypesStatus: Completed, Estimated PCD: 2013-08-01
Clinical trial
A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory FailureStatus: Completed, Estimated PCD: 2020-06-09
Clinical trial
PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related BurnoutStatus: Recruiting, Estimated PCD: 2024-01-01
Clinical trial
[18F]Fluoroestradiol-Positron Emission Tomography (PET)/CT Imaging of Invasive Lobular CarcinomaStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based HeparinStatus: Completed, Estimated PCD: 2019-06-30
Clinical trial
A Phase I/II Clinical Trial To Determine Safety And Feasibility Of Using An Acellular Amniotic Fluid Application To Expedite Healing In Chronic WoundsStatus: Terminated, Estimated PCD: 2023-03-01
Clinical trial
Implications for Management of PET Amyloid Classification TechnologyStatus: Completed, Estimated PCD: 2018-06-01
Clinical trial
Neurobiology of Non-Specific and Specific Treatment Responses in Major DepressionStatus: Withdrawn, Estimated PCD: 2023-05-01
Clinical trial
LIA in Hip Arthroscopy Patients: An Extra-Capsular ApproachStatus: Completed, Estimated PCD: 2020-03-01
Clinical trial
31P-MRS and Resting State Functional Connectivity Analysis of the Effects of 5-hydroxytryptophan and Creatine for Antidepressant Augmentation in Patients With SSRI/SNRI-resistant Major Depressive DisorderStatus: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
A Multi-modality Imaging Assessment of ChemobrainStatus: Completed, Estimated PCD: 2015-02-05
Clinical trial
Rates of Contraceptive Failure When Unprotected Intercourse Has Occurred 6-14 Days Prior to Contraceptive InitiationStatus: Active (not recruiting), Estimated PCD: 2025-01-01
Clinical trial
Ketamine Assisted Psychotherapy for Opioid Use DisorderStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
In Vivo Study of Safety, Tolerability and Dosing Effect on SMN mRNA and Protein Levels of Valproic Acid in Patients With Spinal Muscular AtrophyStatus: Completed
Clinical trial
Pharmacokinetics of Amiloride Nasal Spray in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-08-30
Clinical trial
A Phase I Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple MyelomaStatus: Terminated, Estimated PCD: 2021-12-09
Clinical trial
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKDStatus: Recruiting, Estimated PCD: 2025-03-31
Clinical trial
Hydroxychloroquine for Outpatients With Confirmed COVID-19Status: Completed, Estimated PCD: 2021-10-30
Clinical trial
Practice Effects and Amyloid Imaging Using 18F-PIB (18F-39-F-6-OH-BTA1) Known as [18FGE067]) or Flutemetamol PET and FDG-PETStatus: Completed, Estimated PCD: 2016-05-01
Clinical trial
[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE: Functional Precision Oncology for Metastatic Breast Cancer Feasibility TrialStatus: Recruiting, Estimated PCD: 2025-04-30
Clinical trial
Genetic Susceptibility to Periprosthetic Joint Infections of the Hip and KneeStatus: , Estimated PCD: 2028-03-01
Clinical trial
Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease With and Without Orthostatic Hypotension: a Cross-over StudyStatus: Completed, Estimated PCD: 2023-05-01
Clinical trial
A Phase II Study of Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN DeletionStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
SHAPER: A Phase 1 Study of Losartan and Hypofractionated Radiation Therapy After Induction Chemotherapy for Borderline Resectable or Locally Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2025-08-08
Abstract
Cost-effectiveness analysis (CEA) of seven treatment regimens in metastatic hormone-sensitive prostate cancer (mHSPC): A public payer perspective using network meta-analysis.Org: Huntsman Cancer Institute at the University of Utah, University of Utah, Case Western Reserve University School of Medicine, University of Utah/Huntsman Cancer Institute,
Abstract
RT-PACE: Phase I/II study of adjuvant whole pelvic hypofractionated radiotherapy for non-metastatic cervical and endometrial cancer.Org: University of Chicago, University of Utah, Hunstman Cancer Institute at the University of Utah, The University of Chicago Medicine Center for Advanced Care at Orland Park,
Abstract
Should I stay, or should I go? Factors associated with intent to leave academic oncology.Org: University of California San Francisco, University of Utah, Dana-Farber Cancer Institute, Harvard Medical School, Memorial Sloan Kettering Cancer Center,
Abstract
Pan tumor outcomes to immune checkpoint inhibitors in patients of Native American origin in the United States: The multicenter POINT-US study.Org: Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Avera Cancer Institute, Sioux Falls, SD, The University of Arizona, Tucson, AZ, Huntsman Cancer Institute,
Abstract
Workplace sexual harassment in academic oncology.Org: Memorial Sloan Kettering Cancer Center, New York Oncology Hematology PC, Middletown, Association of American Medical Colleges, Alexandria, VA,
Abstract
Geographical impact on prostate cancer genetic testing eligibility: A preliminary study from an academic cancer center.Org: University of Utah, Hunstman Cancer Institute at the University of Utah, Huntsman Cancer Institute,
Abstract
Patient-reported outcomes during pelvic radiation therapy: A secondary analysis on sexual function from NRG-RTOG 1203.Org: NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, PA, University of California - Irvine, University of Florida Department of Health Outcomes and Biomedical Informatics, University of Oklahoma Health Sciences Center, Summa Health Medical Group,
Abstract
High dose ipilimumab (Ipi) plus temozolomide (TMZ) after progression on standard or low dose Ipi in advanced melanoma.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Utah, Huntsman Cancer Institute, Intermountain Medical Center,
Abstract
A phase 2 single-arm study of berzosertib in combination with irinotecan in patients with progressive TP53 mutant gastric and gastro-esophageal junction cancer.Org: Vanderbilt University Medical Center, Hunstman Cancer Hospital, University of Utah Health, University of Utah, University of California Irvine, University of Pittsburgh Medical Center (UPMC),
Abstract
A phase 1b, open-label, two-part safety, tolerability, and efficacy study of a soluble beta-glucan (odetiglucan) in combination with a CD40 agonistic monoclonal antibody (CDX-1140) in patients with metastatic pancreatic adenocarcinoma whose disease did not progress during first-line (1L) chemotherapy.Org: Hospital of the University of Pennsylvania, Hunstman Cancer Institute at the University of Utah, University of Utah, Memorial Sloan Kettering Cancer Center, Celldex Therapeutics,
Abstract
Differential tumor gene expression profiling of obese and non-obese patients (pts) with prostatic adenocarcinoma (PC).Org: Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, UTC Therapeutics, Huntsman Cancer Institute, University of Utah,
Abstract
Selinexor (SEL) plus ruxolitinib (RUX) in JAK inhibitor (JAKi) treatment-naïve patients with myelofibrosis: Updated results from XPORT-MF-034.Org: City of Hope National Medical Center, Vanderbilt-Ingram Cancer Center, VCU Massey Cancer Center, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute,
Abstract
The final analysis of a phase I/II study of nivolumab, ipilimumab combined with nintedanib in advanced non-small cell lung cancer.Org: Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, Moffitt Cancer Center, Tampa, FL,
Abstract
Multi-omic characterization of gastrointestinal stromal tumor (GIST) in a large real-world patient cohort.Org: Sylvester Comprehensive Cancer Center, Miami, FL, University of Miami Miller School of Medicine, Miami, FL, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Caris Life Sciences, Irving, TX, Lombardi Comprehensive Cancer Center,
Abstract
Telemedicine-supervised cancer therapy for patients with an aggressive lymphoma and metastatic lung cancer in the U.S. Veterans Affairs National TeleOncology Service.Org: Durham VA Medical Center, Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, VA Salt Lake City Health Care, VHA National Oncology Program Office, University of Utah,
Abstract
Real-world treatment trends and outcomes in elderly patients with metastatic colorectal cancer in the United States.Org: Cleveland Clinic Taussig Cancer Instititute, Huntsman Cancer Institute, University of Utah,
Abstract
Patient-reported outcomes (PROs) among men receiving talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as first-line (1L) treatment for metastatic castration-resistant prostate cancer (mCRPC): Results from a phase 3 study (TALAPRO-2).Org: Huntsman Cancer Institute, University of Utah, Medical Oncology Group, Peter MacCallum Cancer Centre, Melbourne, Australia, Sir Peter MacCallum Department of Oncology,
Abstract
Epidemiologic characteristics, treatment patterns, and survival analysis of plasmablastic lymphoma in the US.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Utah, Hunstman Cancer Institute at the University of Utah,
Abstract
Impact of synchronous (sync) vs metachronous (meta) metastasis at the presentation on survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor signaling inhibitors (ARSIs).Org: Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, UTC Therapeutics, Hunstman Cancer Institute at the University of Utah, City of Hope Comprehensive Cancer Center,
Abstract
CAN-2409 plus prodrug with standard of care immune checkpoint inhibitor for patients with stage III/IV NSCLC.Org: University of Pennsylvania, NYU Langone Medical Center, Vanderbilt University Medical Center, University of Chicago, Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic,
Abstract
Clinical characteristics of interval breast cancer within 12 months and 13-24 months in Utah.Org: University of Utah, Intermountain Healthcare, Hunstman Cancer Institute at the University of Utah, University of Utah Division of Genetic Epidemiology,
Abstract
Efficacy of sacituzumab govitecan (SG) in locally advanced (LA) or metastatic urothelial cancer (mUC) by trophoblast cell surface antigen 2 (Trop-2) expression.Org: Institut de Cancérologie Gustave Roussy, Villejuif, France, France, Perlmutter Cancer Center at NYU Langone Health Medical Center, New York, NY,
Abstract
Ibrutinib dose modifications for management of cardiac adverse events in patients with B-cell malignancies: Pooled analysis of 10 clinical trials.Org: Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, CLL Center, Dana-Farber Cancer Institute,
Abstract
Elevated cancer risk among individuals with combinations of cancer-related risk factors: A large claims database analysis.Org: GRAIL LLC, LLC, Illumina, Inc., Inc., Menlo Park, CA,
Abstract
Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases.Org: Ann & Robert H. Lurie Children's Hospital, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Division of Pediatric Surgery, Medical College of Wisconsin, Department of Surgery, St. Jude Children's Research Hospital, Division of Pediatric Surgery, Department of Surgery, Nationwide Children's Hospital,
Abstract
Academic medical center access and outcomes in Kaposi sarcoma.Org: Creighton University School of Medicine Phoenix Regional Campus, Division of Hematology/Oncology, Department of Medicine, University Of Toledo, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Utah,
Abstract
Financial hardship among siblings of long-term survivors of childhood cancer: A Childhood Cancer Survivor Study (CCSS) report.Org: Cancer and Blood Disorders Center, Seattle Children's Hospital, St. Jude Children's Research Hospital, CHOC Hem, Department of Pediatrics & Adolescent Medicine, Queen Mary Hospital,
Abstract
Talazoparib (TALA) plus enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC): Safety analyses from the randomized, placebo (PBO)-controlled, phase 3 TALAPRO-2 study.Org: Peter MacCallum Cancer Centre, Melbourne, Australia, Melbourne, Australia, Australian Catholic University, Institut Gustave Roussy, University of Paris-Saclay,
Abstract
Impact of disadvantaged socioeconomic and demographic status on survival in Kaposi sarcoma.Org: Creighton University School of Medicine Phoenix Regional Campus, Division of Hematology/Oncology, Department of Medicine, University Of Toledo, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Utah,
Abstract
Risk of inpatient and emergency department visits among lung cancer patients receiving immunotherapies as first line treatment: Findings from a linked population dataset.Org: University of Utah, Johns Hopkins University Bloomberg School of Public Health, Huntsman Cancer Institute, Hunstman Cancer Institute at the University of Utah,
Abstract
Socioeconomic and demographic factors on academic center accessibility in sebaceous adenocarcinoma: An NCDB analysis.Org: Creighton University School of Medicine Phoenix Regional Campus, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Utah,
Abstract
Examination of real-world data from geriatric assessments in a comprehensive cancer center to explore predominant and cancer-specific domains for intervention.Org: University of Utah Hospital, Huntsman Cancer Institute, University of Utah, Huntsman Cancer Institute at the University of Utah, Huntsman Cancer Institute (NCI-CCC),
Clinical trial
A Phase 1B, Open Label, Dose-finding Study to Evaluate the Safety and Tolerability of Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)Status: Completed, Estimated PCD: 2020-04-14